Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2354-2358

  Nonaka, Ryoji ^a   Nishimura, Junichi ^a   Kagawa, Yoshinori ^a   Osawa, Hideki ^a   Hasegawa, Junichi ^b   Murata, Kohei ^c   Okamura, Shu ^c   Ota, Hirofumi ^d   Uemura, Mamoru ^a   Hata, Taishi ^a   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Okuzaki, Daisuke ^e   Yamamoto, Hirofumi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c Suita Municipal Hospital   (Japan)

^d Saiseikai Senri Hospital   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Circulating miR; Colorectal cancer; MiR 199a 3p

Indexed keywords

LET 7A; MICRORNA; MICRORNA 199A-3P; UNCLASSIFIED DRUG; MIRN199 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NON INVASIVE MEASUREMENT; POSTOPERATIVE PERIOD; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; GENETICS; PREOPERATIVE PERIOD;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84914680198     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3515     Document Type: Article

References (19)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Jemel A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. O'Connell JB, Maggard MA and Ko CY: Colon cancer survival rates with the new American joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 6: 1420-1425, 2004
4. Hewitson P, Glasziou P, Watson E, Towler B and Irwig L: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103: 1541-1549, 2008.
5. Walsh JM and Terdiman JP: Colorectal cancer screening: scientific review. JAMA 289: 1288-1296, 2003.
6. Baxter NN, Warren JL, Barrett MJ, Stukel TA and Doria-Rose VP: Association between colonoscopy and colorectal cancer mortality in a uS cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30: 2664-2669, 2012.
7. Winawer S, Fletcher R, Rex D, et al: Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 124: 544-560, 2003.
8. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005
9. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
10. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
11. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Nat Acad Sci USA 105: 10513-10518, 2008.
12. Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437, 2011.
13. Pu XX, Huang GL, Guo HQ, et al: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25: 1674-1680, 2010.
14. Ng EK, Chong WW, Jin H, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009
15. Huang Z, Huang D, Ni S, Peng Z, Sheng W and Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126, 2010.
16. Cheng H, Zhang L, Cogdell DE, et al: Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6: e17745, 2010.
17. Toiyama Y, Takahashi M, Hur K, et al: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105: 849-859, 2013.
18. Wan D, He S, Xie B, et al: Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers. Med Oncol 30: e378, 2013.
19. Ahmed FE, Ahmed NC, Vos PW, et al: Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 10: 93-113, 2013.